These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7842293)

  • 1. Human lung tumor cell secretion of interleukin-2 for protection against tumor engraftment.
    Alosco T; Gansbacher B; Bankert R; Takita H; Petrelli N
    Ann Surg Oncol; 1994 May; 1(3):229-35. PubMed ID: 7842293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of antitumor immunity by interleukin-2 gene-transduced mouse mammary tumor cells versus transduced mammary stromal fibroblasts.
    Tsai SC; Gansbacher B; Tait L; Miller FR; Heppner GH
    J Natl Cancer Inst; 1993 Apr; 85(7):546-53. PubMed ID: 8455201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-gamma in irradiated human melanoma cells.
    Gansbacher B; Zier K; Cronin K; Hantzopoulos PA; Bouchard B; Houghton A; Gilboa E; Golde D
    Blood; 1992 Dec; 80(11):2817-25. PubMed ID: 1450408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of antitumor immunity by tumor cells transduced with a retroviral vector carrying the interleukin-2 and interferon-gamma cDNAs.
    Rosenthal FM; Cronin K; Bannerji R; Golde DW; Gansbacher B
    Blood; 1994 Mar; 83(5):1289-98. PubMed ID: 8118032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of interleukin-2 transduction on the human hepatoma cell lines using retroviral vector.
    Kim JH; Gong SJ; Yoo NC; Lee H; Shin DH; Uhm HD; Jeong SJ; Cho JY; Rha SY; Kim YS; Chung HC; Roh JK; Min JS; Kim BS
    Oncol Rep; 1999; 6(1):49-54. PubMed ID: 9864400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine gene therapy with interleukin-2-transduced fibroblasts: effects of IL-2 dose on anti-tumor immunity.
    Fakhrai H; Shawler DL; Gjerset R; Naviaux RK; Koziol J; Royston I; Sobol RE
    Hum Gene Ther; 1995 May; 6(5):591-601. PubMed ID: 7578396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
    Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL
    Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroviral-mediated IL-2 gene transfer into murine neuroblastoma.
    Cho HS; Song JY; Park CY; Lyu CJ; Kim BS; Kim KY
    Yonsei Med J; 2000 Feb; 41(1):76-81. PubMed ID: 10731923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor efficacy of a human interleukin-12 expression plasmid demonstrated in a human peripheral blood leukocyte/human lung tumor xenograft SCID mouse model.
    Hess SD; Egilmez NK; Shiroko J; Bankert RB
    Cancer Gene Ther; 2001 May; 8(5):371-7. PubMed ID: 11477457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of antitumor immunity by combined immunogene therapy using IL-2 and IL-12 in low antigenic Lewis lung carcinoma.
    Tanaka M; Saijo Y; Sato G; Suzuki T; Tazawa R; Satoh K; Nukiwa T
    Cancer Gene Ther; 2000 Nov; 7(11):1481-90. PubMed ID: 11129290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transduction of human melanoma cells with interleukin-2 gene reduces tumorigenicity and enhances host antitumor immunity: a nude mouse model.
    Abdel-Wahab Z; Li WP; Osanto S; Darrow TL; Hessling J; Vervaert CE; Burrascano M; Barber J; Seigler HF
    Cell Immunol; 1994 Nov; 159(1):26-39. PubMed ID: 7954840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells.
    Gastl G; Finstad CL; Guarini A; Bosl G; Gilboa E; Bander NH; Gansbacher B
    Cancer Res; 1992 Nov; 52(22):6229-36. PubMed ID: 1423266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccines.
    Belldegrun A; Tso CL; Sakata T; Duckett T; Brunda MJ; Barsky SH; Chai J; Kaboo R; Lavey RS; McBride WH
    J Natl Cancer Inst; 1993 Feb; 85(3):207-16. PubMed ID: 8423625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor response independent of functional B or T lymphocytes induced by the local and sustained release of interleukin-2 by the tumor cells.
    Alosco T; Croy BA; Gansbacher B; Wang HQ; Rao U; Bankert R
    Cancer Immunol Immunother; 1993 Jun; 36(6):364-72. PubMed ID: 8500109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterization of an interleukin-2-transduced human ovarian carcinoma tumor vaccine not expressing major histocompatibility complex molecules.
    Santin AD; Ioli GR; Hiserodt JC; Manetta A; Pecorelli S; DiSaia PJ; Granger GA
    Am J Obstet Gynecol; 1996 Feb; 174(2):633-40. PubMed ID: 8623798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of tumorigenicity of human pancreatic carcinoma cells engineered to produce interleukin-2 or interleukin-4 in nude mice: a potentiality for cancer gene therapy.
    Kimura M; Tagawa M; Takenaga K; Kondo F; Yamaguchi T; Saisho H; Nakagawara A; Sakiyama S
    Cancer Lett; 1998 Jun; 128(1):47-53. PubMed ID: 9652792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory effects of human neuroblastoma cells transduced with a retroviral vector encoding interleukin-2.
    Leimig T; Foreman N; Rill D; Coze C; Holladay M; Brenner M
    Cancer Gene Ther; 1994 Dec; 1(4):253-8. PubMed ID: 7627815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient tumor regression induced by genetically engineered tumor cells secreting interleukin-2 and membrane-expressing allogeneic MHC class I antigen.
    Qian SB; Li Y; Qian GX; Chen SS
    J Cancer Res Clin Oncol; 2001 Jan; 127(1):27-33. PubMed ID: 11206268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of irradiation on cytokine production, MHC antigen expression, and vaccine potential of interleukin-2 and interferon-gamma gene-modified melanoma cells.
    Abdel-Wahab Z; Dar MM; Hester D; Vervaert C; Gangavalli R; Barber J; Darrow TL; Seigler HF
    Cell Immunol; 1996 Aug; 171(2):246-54. PubMed ID: 8806794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-7 gene transfer in non-small-cell lung cancer decreases tumor proliferation, modifies cell surface molecule expression, and enhances antitumor reactivity.
    Sharma S; Wang J; Huang M; Paul RW; Lee P; McBride WH; Economou JS; Roth MD; Kiertscher SM; Dubinett SM
    Cancer Gene Ther; 1996; 3(5):302-13. PubMed ID: 8894249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.